MITSUBISHI GAS CHEMICAL COMPANY, INC.
4182・Prime Market・Chemicals
Green Energy & Chemical Division
A basic chemicals segment centered on methanol and aromatic chemicals, with high dependence on equity-method investment gains/losses.
| Period | Current | Previous | Change |
|---|---|---|---|
| Segment Sales (External Customers) | ¥277,904 million | ¥313,392 million | ↓ |
| Segment Sales (Including Internal Sales, Total) | ¥286,924 million | ¥323,199 million | ↓ |
| Segment Ordinary Income | ¥3,857 million | ¥20,516 million | ↓ |
| Segment Assets | ¥415,814 million | ¥464,140 million | ↓ |
| Depreciation | ¥13,217 million | ¥13,751 million | ↓ |
| Equity in Earnings/Losses of Affiliates | △¥807 million | ¥8,035 million | ↓ |
| Impairment Loss | ¥56,145 million | ¥258 million | ↓ |
| Investments in Equity-Method Affiliates | ¥143,348 million | ¥140,689 million | ↑ |
Business Details
Manufactures and sells methanol, methanol/ammonia-based chemicals, life science products, general-purpose and specialty aromatic chemicals, foamed plastics, electricity, and other products. Holds numerous equity-method investments in overseas methanol production companies (Trinidad and Tobago, etc.), giving the segment a structure in which methanol market conditions have a significant impact on ordinary income. Meta-xylylenediamine (MXDA) / Aromatic Aldehyde and Xylene Separation/Derivatives are also key product groups. As a priority management initiative, the company is proceeding with withdrawal from the ortho-xylene chain.
Recent Overview
Ordinary income sharply declined due to falling methanol market conditions, intensifying MXDA competition, and large-scale impairment losses recorded at multiple sites.
In FY2026 (ending March 2026), the methanol business recorded lower revenue and profit due to a decline in methanol market conditions, and an impairment loss was recorded at the methanol production company in Trinidad and Tobago. Equity in earnings of affiliates deteriorated from ¥8,035 million (previous fiscal year) to △¥807 million. MXDA and its derivatives saw revenue and profit decline due to falling selling prices amid intensifying competition and rising fixed costs, and an impairment loss on fixed assets was also recorded at the MXDA manufacturing subsidiary in the Netherlands. Total impairment losses for the segment reached ¥56,145 million. Withdrawal from the ortho-xylene chain business is ongoing.
Key Products
Growth Drivers
- Recovery in methanol market conditions and improvement in equity-method earnings/losses at overseas equity-method affiliates (Trinidad and Tobago, Brunei, Saudi Arabia, etc.) (an improvement in equity-method income is expected in the forecast for the next fiscal year)
- Reduced depreciation expense effect resulting from the impairment losses recorded (lower fixed cost burden from the next fiscal year onward)
- Realization of the Carbopath™ environmentally circular methanol concept and efforts toward the practical application of CCS
- Solid demand in the energy resources business, including iodine and geothermal power generation
- Improved profitability through restructuring of priority management businesses, including withdrawal from the ortho-xylene chain
Risks
- Risk of fluctuations in methanol market conditions (a decline in market conditions directly affects ordinary income through equity-method earnings/losses)
- Intensifying competition in the meta-xylylenediamine business (price competition with Chinese and other competitors, declining sales volume, rising fixed costs)
- Risk of impairment of fixed assets at overseas manufacturing subsidiaries (large-scale impairment losses recorded in FY2026 (ending March 2026) at the MXDA subsidiary in the Netherlands, the methanol production company in Trinidad and Tobago, and others)
- Risk of rising energy prices and tightening raw material supply due to escalating tensions in the Middle East (not fully factored into the forecast for the next fiscal year)
- Sluggish demand for derivative products due to the prolonged economic slowdown in China
- Geopolitical risk and foreign exchange fluctuation risk
Other Businesses
A complementary segment handling purchase and sales operations not belonging to the two main segments
| Period | Current | Previous | Change |
|---|---|---|---|
| Sales to External Customers | ¥12,339 million | ¥16,470 million | ↓ |
| Segment Ordinary Income | ¥1,324 million | ¥1,125 million | ↑ |
| Segment Assets | ¥49,583 million | ¥46,517 million | ↑ |
| Depreciation | ¥139 million | ¥126 million | ↑ |
| Capital Expenditure (Increase in Tangible/Intangible Fixed Assets) | ¥98 million | ¥90 million | ↑ |
Business Details
"Other Businesses" is a complementary segment that includes purchase and sales operations and other activities that do not belong to either the Green Energy & Chemical Division or the Functional Chemicals Division. It has a business structure centered on purchase and sales with almost no manufacturing function, and segment assets and capital expenditures are minor. In FY2026 (ending March 2026), sales to external customers declined to ¥12,339 million from ¥16,470 million in the previous fiscal year, while segment ordinary income increased to ¥1,324 million from ¥1,125 million in the previous fiscal year.
Recent Overview
Revenue declined, but ordinary income increased year on year
In FY2026 (ending March 2026), sales to external customers declined by approximately 25% to ¥12,339 million from ¥16,470 million in the previous fiscal year. Meanwhile, segment ordinary income increased by approximately 17.7% to ¥1,324 million from ¥1,125 million in the previous fiscal year. Segment assets increased to ¥49,583 million from ¥46,517 million at the end of the previous fiscal year. Capital expenditure remained at a minor level of ¥98 million, with no change to the business structure centered on purchase and sales without manufacturing function.
Key Products
Growth Drivers
- While sales scale is on a declining trend, profitability (ordinary income margin) has improved, achieving an increase in profit year on year in FY2026 (ending March 2026)
- Segment assets have increased compared to the end of the previous fiscal year, indicating progress in expanding the business foundation
Risks
- Since the segment's business activities are comprehensively defined as "purchase and sales, etc." without disclosure of specific details on products, customers, or markets, it is difficult to identify the factors driving performance fluctuations
- Sales to external customers declined significantly to ¥12,339 million in FY2026 (ending March 2026) compared to ¥16,470 million in the previous fiscal year, indicating that the actual business scale is on a shrinking trend
- With capital expenditure of only ¥98 million against segment assets of ¥49,583 million (as of the end of FY2026, ending March 2026), the investment scale is extremely small, limiting the scope for growth investment
Last updated: July 17, 2026

